Epistem, Xcelris Genomics deal

EpiStem granted Xcelris Indian commercialization rights to Genedrive molecular test. EpiStem will be responsible for regulatory approval for the diagnostic to diagnose tuberculosis (TB) infection. EpiStem said the Genedrive technology is applicable to a range of viral, bacterial, fungal and somatic mutation disease area. Terms were not disclosed. ...